Indicated for the treatment of chronic hypoparathyroidism in adults.
NOW APPROVED IN AUSTRALIA
For assistance with forgotten passwords or access issues, please contact your regional ST Liaison or email our Marketing and Comms team at planger@stbiopharma.com
This page is for Australian Healthcare Professionals only.
Please confirm you are an Australian Healthcare Professional.